Digital health apps may have limited role in reduction of migraine symptoms
1. Among adult patients with migraine headaches, the use of a prescribed digital health app did not reduce the number...
Living in a marginalized neighbourhood is associated with worse outcomes in patients with myocardial infarction
1. In acute myocardial infarction (AMI) survivors younger than the age of 65, living in a marginalized neighbourhood was associated...
SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
1. In elderly patients 65 years of age or older with heart failure with reduced ejection fraction (HFrEF), regular use...
Oral vancomycin may be effective for pouchitis in inflammatory bowel disease
1. In patients with pouchitis associated with inflammatory bowel disease (IBD) and primary sclerosing cholangitis (PSC), the use of oral...
Fecal calprotectin is a useful marker for defining small bowel endoscopic remission in Crohn’s disease
1. In patients with Crohn’s disease (CD), fecal calprotectin (FC) was a useful biomarker for monitoring small bowel lesions and...
2 Minute Medicine Rewind July 7, 2025
A Prescribed Digital Health App and Number of Migraine Days 1. Among adult patients with migraine headaches, the use of...
Transcatheter closure of patent ductus arteriosus demonstrates similar outcomes compared to surgical repair
1. Respiratory outcomes for preterm infants with a patent ductus arteriosus (PDA) undergoing transcatheter closure compared to surgical ligation did...
Use of psychiatric medications may be associated with a higher risk of amyotrophic lateral sclerosis
1. Prediagnostic use of anxiolytics, hypnotics, sedatives and antidepressants were associated with a higher risk of amyotrophic lateral sclerosis (ALS). ...
Dapagliflozin may improve outcomes in patients with metabolic dysfunction-associated steatohepatitis
1. The use of dapagliflozin in patients with metabolic dysfunction-associated steatohepatitis (MASH) resulted in a higher proportion of improvement of...
Sacituzumab tirumotecan may have a role in the treatment of metastatic non-small cell lung cancer
1. In patients with previously treated metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC), treatment with sacituzumab...